Recent News

• 05.19.2026 - Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural Validation
• 05.19.2026 - Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural Validation
• 05.19.2026 - Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural Validation
• 05.19.2026 - Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural Validation
• 04.29.2026 - Autonomix Medical Announces Abstract Acceptance at Digestive Disease Week 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation
• 03.11.2026 - Autonomix Medical to Present at LSI USA ’26
• 12.23.2025 - Autonomix Medical, Inc. (NASDAQ: AMIX) Highlights Expanding IP Portfolio and Multi-Indication Platform Strategy in Virtual Investor CEO Connect Segment

Recent Filings

• 04.02.2026 - S-8 Securities to be offered to employees in employee benefit plans
• 02.11.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 01.16.2026 - 8-K Current report
• 01.09.2026 - 8-K Current report
• 01.09.2026 - EX-99.1 EX-99.1
• 12.12.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 12.11.2025 - EFFECT Notice of Effectiveness
• 11.26.2025 - S-3 Registration statement under Securities Act of 1933
• 11.19.2025 - 8-K Current report
• 11.12.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]